By combining PocDoc's screening infrastructure with IQVIA's expertise across healthcare data, technology, clinical research and commercialisation, the partnership will help healthcare systems and pharmaceutical companies develop, launch and scale cardiovascular treatment programmes faster and more efficiently.

Steve Roest, chief executive and co-founder of PocDoc, said: ‘Despite major advances in cardiovascular therapeutics, those advances can only make a difference if we identify the people at risk. That means making cardiovascular testing far more accessible and ensuring the results can connect into the wider healthcare system.

‘IQVIA brings extensive expertise across life sciences, data and health systems, while PocDoc has built the digital infrastructure to make cardiovascular risk identification accessible at scale. Together, we can help close the gap between screening and care, and this is just the start of what that collaboration can do.'

The collaboration brings together PocDoc's ability to identify cardiovascular risk across a wide range of settings with IQVIA's expertise across the life sciences industry, creating a more connected pathway between patient identification, healthcare systems and the development and delivery of new treatments.